C. Ferme et al., THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE, Annals of oncology, 6(6), 1995, pp. 543-549
Background: Relapsed or refractory Hodgkin's disease (HD) patients wer
e treated with an intensive salvage regimen (MINE) prior to high-dose
therapy (HDT) with hematopoietic stem cell support. Patients and metho
ds: One hundred HD patients who either failed to respond to a front-li
ne chemotherapy regimen (induction failure, n = 41) or relapsed (untre
ated relapse, n = 54; resistant relapse, n = 5) were treated with the
MINE regimen. Each course of MINE comprised mitoguazone 500 mg/ m(2) o
n days 1 and 5, ifosfamide 1500 mg/m(2)/d from day 1 to day 5, vinorel
bine (Navelbine(R)) 15 mg/m(2) on days 1 and 5, and etoposide 150 mg/m
(2)/d from day 1 to day 3. At least two courses were given at 4-week i
ntervals. Then, 72 patients received HDT followed by hematopoietic ste
m cell support. Results: After MINE salvage, 34 patients achieved a co
mplete response (CR) and 39 a partial response, yielding an overall re
sponse rate of 75%. Patients with untreated relapse had a 92.5% respon
se rate and those with resistant relapse or induction failure a 53% re
sponse rate. A total of 58 patients reached a CR at the end of all tre
atments; 12 of them relapsed. Sixty-six patients were alive with a med
ian follow-up of 26 months, including 46 patients in CR. The 2-year su
rvival rate for the entire group was 59%. By univariate analysis, pati
ents with an interval between their last treatment and salvage longer
than 12 months, untreated relapse, or good performance status at salva
ge are shown to have longer survivals. The main toxic effects were neu
tropenia, thrombocytopenia, and infectious episodes. Three patients di
ed of MINE-related complications and three after HDT. Conclusion: Give
n early in the course of progressive HD, the MINE regimen reduced tumo
r burden in a high proportion of patients with relapsed or refractory
disease. Responding patients further intensified with HDT have a bette
r outcome than those who have not responded to salvage treatment.